Abstract
Clinical outcomes of adrenocortical carcinomas (ACC) could be improved by using novel treatment targets based on the recent advances of tumor biology knowledge. Insulin-like growth factor 2 (IGF2) protein expression is usually 8-80 fold higher in ACC when compared to normal adrenal glands (N-AG) or adrenocortical adenomas (ACA), despite the fact that the biological features of high vs. low IGF2 expressing ACC have not yet been well characterized. Our goal was to understand the IGF2 role in ACC biology by focusing in several cancer hallmarks, including cell proliferation, viability, invasion, and metabolism. IGF2 immunohistochemistry expression was evaluated in ACC (n = 13), non-functioning adrenocortical adenoma (ACAn) (n = 14), and N-AG (n = 9). The effects of IGF2 (50, 100 ng/mL) in cell proliferation, viability, invasion, and metabolism, as well as in MAPK/ERK and mTOR pathways activation and N-cadherin expression, were evaluated in the ACC human cell line H295R. IGF2 expression was increased in ACC compared to ACAn and N-AG. Exposure to 100 ng/mL of IGF2 increased H295R cell proliferation and viability. mTOR inhibition reverted IGF2 triggered cell proliferation and viability while MEK/MAPK/ERK inhibition only reverted IGF2 ...Continue Reading
References
Sep 1, 1993·The Journal of Clinical Endocrinology and Metabolism·V IlvesmäkiR Voutilainen
May 20, 1998·The Journal of Clinical Endocrinology and Metabolism·N BoulleY Le Bouc
Jul 30, 1999·Journal of Molecular Endocrinology·A LogiéC Gicquel
Apr 13, 2002·Endocrine Pathology·L A EricksonR V Lloyd
Sep 6, 2005·Cancer Research·Frédérique TissierJérôme Bertherat
Aug 22, 2006·Histopathology·A SchmittA Perren
Feb 10, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rossella LibèJérôme Bertherat
Aug 2, 2007·Nature Reviews. Molecular Cell Biology·Judith Campisi, Fabrizio d'Adda di Fagagna
Jun 3, 2008·The Oncologist·Patsy S H SoonStan B Sidhu
Feb 17, 2009·Endocrine-related Cancer·P S H SoonS B Sidhu
May 21, 2010·Cancer Research·Mabrouka DoghmanEnzo Lalli
Jan 29, 2011·NMR in Biomedicine·Marco G AlvesRui A Carvalho
Oct 25, 2011·Molecular and Cellular Endocrinology·Tamaya Castro Ribeiro, Ana Claudia Latronico
Mar 16, 2012·Endocrine-related Cancer·Maria Cristina De MartinoLeo J Hofland
May 9, 2012·Cancer Genetics·Tomasz Lehmann, Tomasz Wrzesinski
Feb 19, 2013·Endocrine·M FraenkelD J Gross
Apr 30, 2013·PloS One·Hengchuan SuFukang Sun
Aug 9, 2013·Endocrine Connections·Sofia S PereiraDuarte Pignatelli
Oct 2, 2013·Endocrine-related Cancer·Callum Livingstone
Oct 2, 2013·The Journal of Clinical Endocrinology and Metabolism·Martin FassnachtBruno Allolio
Jan 16, 2014·Endocrine Reviews·Tobias ElseGary D Hammer
Jun 4, 2014·Endocrine-related Cancer·Maria Cristina De MartinoLeo J Hofland
Jun 26, 2014·Journal of Visualized Experiments : JoVE·Calvin R JustusLi V Yang
Aug 5, 2014·PloS One·Marine Guillaud-BatailleEric Clauser
Oct 3, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wade T Iams, Christine M Lovly
Nov 26, 2015·Oncogene·L JinS Kang
May 12, 2016·Cancer Cell·Siyuan ZhengRoel G W Verhaak
Aug 6, 2016·Nature Reviews. Cancer·Brian J AltmanChi V Dang
Jul 3, 2018·Minerva endocrinologica·Barbara AltieriAntongiulio Faggiano
Sep 27, 2018·Journal of Cellular Biochemistry·Sofia S PereiraDuarte Pignatelli
Mar 7, 2019·Endocrine·Maria Cristina De MartinoLeo J Hofland
Citations
May 14, 2020·Cell Communication and Signaling : CCS·Hai-Xia TanHai-Yan Wang
Aug 13, 2020·Cancers·Marthe ChehadeStan Sidhu
Feb 14, 2021·Biomedicines·Maja MizdrakJoško Božić
Feb 15, 2021·Aging·Yanyan LiWeiyang Cai
Apr 21, 2021·Der Pathologe·Wolfgang Saeger
Jun 3, 2021·Cancers·Mai BadarniMoshe Elkabets
Jul 16, 2021·Rare Tumors·Rui Caetano OliveiraMaria Augusta Cipriano
Jul 22, 2021·European Journal of Drug Metabolism and Pharmacokinetics·Malik Salman HaiderRobert Luxenhofer
Aug 28, 2021·Biomedicines·Hiroki ShimadaYasuhiro Nakamura
May 15, 2021·Journal of Molecular Cell Biology·Weiwei GuiHong Li